If you haven’t yet, you’ve got to tune into the latest episode of Independent Rx Forum. NCPA CEO Douglas Hoey sat down with serial entrepreneur Mark Cuban to talk about Cost Plus Drugs, his latest project that’s turning the industry upside down.
Cuban is joined by Cost Plus Drug General Counsel Erin Albert and well-known industry analyst Antonio Ciaccia. Check it out here.
NCPA
